These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1966307)

  • 1. New approaches in viral vaccine development.
    Brown F
    Scand J Infect Dis Suppl; 1990; 76():39-46. PubMed ID: 1966307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Jenner to genes--the next generation of virus vaccines.
    Brown F
    Biochem Soc Symp; 1987; 53():75-84. PubMed ID: 3332769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gene technology in the diagnosis of viruses and vaccine development].
    Löwer J
    Arzneimittelforschung; 1988 Mar; 38(3A):438-41. PubMed ID: 3134900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foot and mouth disease virus vaccines.
    Rodriguez LL; Grubman MJ
    Vaccine; 2009 Nov; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus vaccines: principles and prospects.
    Melnick JL
    Bull World Health Organ; 1989; 67(2):105-12. PubMed ID: 2663217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
    Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
    Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.
    Taylor J; Paoletti E
    Prog Vet Microbiol Immunol; 1988; 4():197-217. PubMed ID: 3078866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved?
    Bukreyev A; Belyakov IM
    Expert Rev Vaccines; 2002 Aug; 1(2):233-45. PubMed ID: 12901562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms involved in the prolonged humoral immune response: behavior of aphthous fever virus].
    Wigdorovitz A; Sadir A
    Rev Argent Microbiol; 1996; 28(1):45-54. PubMed ID: 8815460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research and development strategies, examples among new vaccines].
    Denis F; Ploy MC
    Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.